glp 1 microdose for inflammation GLP-1 and Gut Health: Addressing Metabolic Dysfunction Physicians GLP-1 Therapies May Benefit MPN

Our 2025 study in JMIR Formative Research examined 12-month outcomes for participants using semaglutide with behavioural support and found 1 : 19.1% average weight loss at 12 months for active subscribers 77.7% achieved at least 10% weight loss 61.5% achieved at least 15% weight loss 69% reported no side effects by month 12 These are completer results (people who stayed on the programme for 12 months), not intent-to-treat

Ingestion of probiotic (Lactobacillus helveticus and bifidobacterium longum) alters intestinal microbial structure and behavioral expression following social defeat stress

What Exactly is Happening in My Body During the Healing Crisis

Mg deficiency can present with symptoms such as aggression, fatigue, nervousness, and attention deficits [124]